| G3P, | G-3-P glyceraldehyde-3-phosphate; glycerol-3-phosphate |
|---|---|
| GPD | glucose-6-phosphate dehydrogenase; glycerol-phosphate dehydrogenase |
| PD | Doctor of Pharmacy; Dublin Pharmacopoeia; interpupillary distance; Paget disease; pancreatic duct; p... |
| PPP | pain perception profile; palatopharyngoplasty; palmoplantar pustulosis; pentose phosphate pathway; p... |
| TCP | T-complex protein; therapeutic continuous penicillin; total circulating protein; transcutaneous pace... |
| copper colic | An affection similar to lead colic occurring in chronic poisoning by copper. (05 Mar 2000) |
|---|---|
| copper dichloride | CuCl2-2H2O;has been used as an antiseptic in the treatment of water supplies, ponds, and pools. Synonym: copper bichloride, copper chloride, copper dichloride. (05 Mar 2000) |
| copper nose | A manifestation of severe acne rosacea resulting in significant enlargement of the nose and occurring primarily in men. It is caused by hypertrophy of the sebaceous glands and surrounding connective tissue. The nose is reddened and marked with numerous telangiectasias. (12 Dec 1998) |
| copper pennies | Vegetative rounded muriform cells of dematiaceous fungi, characteristic of the causal agents of chromoblastomycosis in tissue. Synonym: copper pennies. (05 Mar 2000) |
| copper protein | A protein containing one or more copper ions; e.g., cytochrome c oxidase, phenol oxidase. (05 Mar 2000) |
| copper radioisotopes | Unstable isotopes of copper that decay or disintegrate emitting radiation. Cu atoms with atomic weights 58-62, 64, and 66-68 are radioactive copper isotopes. (12 Dec 1998) |
| copper sulfate | <chemical> The pentahydrate sulfate salt of copper. It is a powerful emetic and used orally as an antidote to phosphorus poisoning. Topical application of a 1 per cent solution is used in the treatment of phosphorus burns of the skin. It is also used as a catalyst with iron in the treatment of iron-deficiency anaemia. In 1:1,000,000 concentration it is used to prevent growth of algae in ponds, reservoirs, and swimming pools. Pharmacological action: antidotes, emetics, fungicides, industrial. (12 Dec 1998) |
| copper sulfate method | A method for the determination of specific gravity of blood or plasma in which the blood or plasma is delivered by drops into solutions of copper sulfate graded in specific gravity by increments of 0.004, each of the bottles of solution being within the expected range of the blood or plasma sample; the specific gravity of the copper sulfate solution in which the drop of blood or plasma remains suspended indefinitely indicates the specific gravity of the sample. (05 Mar 2000) |
| copper sulphate | CuSo4-5H2O;it is highly poisonous to algae, is a prompt and active emetic, and is used as an irritant, astringent, and fungicide. Synonym: copper sulfate, copper sulphate. (05 Mar 2000) |
| intrauterine devices, copper | Intrauterine contraceptive devices that depend on the release of metallic copper. (12 Dec 1998) |
| acetyl phosphate | CH3CO-OPO32-;a "high energy" phosphate that acts as an acetate donor in the metabolism of various bacteria. Synonym: acetic phosphoric anhydride. (05 Mar 2000) |
| acidulated phosphate fluoride | <chemical> Phosphoric acid, mixt. With sodium fluoride (naf). A sodium fluoride solution, paste or powder, which has been acidulated to pH 3 to 4 and buffered with a phosphate. It is used in the prevention of dental caries. Pharmacological action: fluorides, topical. Chemical name: Phosphoric acid, mixt. With sodium fluoride (NaF) (12 Dec 1998) |
| acyl dihydroxyacetone phosphate oxidoreductase | <enzyme> Forms acyl-sn-glycerol 3-phosphate; uses NADPH Registry number: EC 1.1.1.- (26 Jun 1999) |
| adenosine 3',5'-cyclic phosphate phosphodiesterase | <enzyme> An enzyme that catalyses the hydrolysis of adenosine 3',5'-cyclic phosphate forming 5'-AMP. A crucial step in the regulation of cellular adenosine 3',5'-cyclic phosphate levels. Inhibited by caffeine. Synonym: cAMP phosphodiesterase. (05 Mar 2000) |
| adenosine 3'-phosphate | 3'-Adenylic acid. See: adenylic acid. (05 Mar 2000) |